SCHLACKMAN SCOTT 4

What Happened
Scott Schlackman, a director of Medifast, purchased a total of 5,000 shares of MED common stock in two open-market transactions. He acquired 2,500 shares on 2026-05-08 at $12.65 each ($31,625) and another 2,500 shares on 2026-05-11 at $12.53 each ($31,325), for a combined cash outlay of $62,950. These were purchases (transaction code P), which insiders’ buys are often viewed as a stronger signal than routine sales.

Key Details

• Transaction dates & prices:
  • 2026-05-08: 2,500 shares @ $12.65 = $31,625
  • 2026-05-11: 2,500 shares @ $12.53 = $31,325
• Total purchased: 5,000 shares for $62,950.
• Filing: Form 4 filed 2026-05-12 (appears timely relative to the transaction dates).
• Shares owned after transaction: not specified in the information provided in this summary/Form 4 excerpt.
• Footnotes/notable codes: Transaction code P = Purchase. No 10b5-1 plan, tax withholding, or other footnotes were disclosed in the supplied details.

Context
Insider purchases are factual data points that some investors use to gauge insider confidence, but they do not prove future performance. Schlackman is a company director (not indicated as a 10% owner in the provided data). No derivative exercises, gifts, or cashless sales were reported in these transactions.